Treatment of nicotine dependence

Mayo Clinic Proceedings

Volumn 75, Issue 12, 2000, Pages 1311-1316

  Dale, Lowell C ^a   Ebbert, Jon O ^b   Taylor Hays, J ^b   Hurt, Richard D ^a  

^a Nicotine Dependence Center   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIHISTAMINIC AGENT; CLONIDINE; CORTICOSTEROID; NICOTINE; NICOTINE GUM; NORTRIPTYLINE;

BEHAVIOR THERAPY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG MEGADOSE; HUMAN; INDIGESTION; INSOMNIA; NAUSEA; PATIENT COUNSELING; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SKIN IRRITATION; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT; XEROSTOMIA;

EID: 0033662379     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.12.1311     Document Type: Review

References (18)

1. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 1997. MMWR Morb Mortal Wkly Rep. 1999;48:993-996.
2. Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA. 2000;284:706-712.
3. Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. JAMA. 2000;283:3244-3254.
4. Goldstein MG, Niaura R, Willey-Lessne C, et al. Physicians counseling smokers: a population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventions. Arch Intern Med. 1997:157:1313-1319.
5. Dale LC, Hurt RD, Hays JT. Drug therapy to aid in smoking cessation: tips on maximizing patients' chances for success. Postgrad Med. December 1998; 104:75-78, 83-84.
6. Prochaska JO, Goldstein MG. Process of smoking cessation: implications for clinicians. Clin Chest Med. 1991:12:727-735.
7. Rohren CL, Croghan IT, Hurt RD, Offord KP, Marusic Z, McClain FL. Predicting smoking cessation outcome in a medical center from stage of readiness: contemplation versus action. Prev Med. 1994; 23:335-344.
8. Rundmo T, Smedslund G, Gotestam KG. Motivation for smoking cessation among the Norwegian public. Addict Behav. 1997; 22:377-386.
9. National Cancer Institute. Clearing the Air: How to Quit Smoking...and Quit for Keeps. Bethesda, Md: National Institutes of Health, National Cancer Institute; 1995. NIH publication no. 951647.
10. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy: percentage of replacement and smoking cessation. JAMA. 1995;274:1353-1358.
11. Hurt RD, Dale LC, Offord KP, et al. Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther. 1993; 54:98-106.
12. Fredrickson PA, Hurt RD, Lee GM, et al. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology (Bert). 1995;122:215-222.
13. Benowitz NL, Zevin S, Jacob P III. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J Pharmacol Exp Ther. 1998;287:958-962.
14. Hurt RD, Offord KP, Croghan IT, et al. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psvchopharmacology (Bert). 1998; 140:98-104.
15. Hurt RD, Dale LC, Croghan GA, Croghan IT, Gomez-Dahl LC, Offord KP. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Mayo Clin Proc. 1998:73:118-125.
16. Hall SM, Reus VI, Munoz RF, et al. Nortriptyline and cognitivebehavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998:55:683-690.
17. Hurt RD, Dale LC, Offord KP, Brace BK, McClain FL, Eberman KM. Inpatient treatment of severe nicotine dependence. Mavo Clin Proc. 1992:67:823-828.
18. Croghan IT, Offord KP, Evans RW, et al. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience. Mavo Clin Proc. 1997;72:917-924.